-
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 20/09/24 )
NAV
₹30.99
Last change
₹0.09 +0.0%
Fund Size (AUM)
1183.18 Cr
Performance
28.57% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
as of 20/09/24
AUM
1183.18 Cr
Expense Ratio
2.14 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 52.33% | 19.51% | 28.57% |
| Nifty Pharma TR INR | 54.79% | 17.57% | 27.38% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.38% |
Aurobindo Pharma Ltd |
9.83% |
Lupin Ltd |
7.77% |
Dr Reddy's Laboratories Ltd |
7.3% |
Cipla Ltd |
6.85% |
Divi's Laboratories Ltd |
4.52% |
Zydus Lifesciences Ltd |
4.49% |
Fortis Healthcare Ltd |
3.99% |
Alkem Laboratories Ltd |
3.92% |
Apollo Hospitals Enterprise Ltd |
3.45% |
Sector Allocation
Healthcare |
97.93% |
Basic Materials |
2.07% |
Asset Allocation
-
93%
Equity
-
7%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.86% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.97% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.38% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.38% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
28.57% (5Y)
-
-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare-
Returns
-
28.57% (5Y)
-
